Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tripartite motif-containing protein 49D2 (TRIM49D2) is a predicted E3 ubiquitin-protein ligase implicated in protein ubiquitination, innate immune response, and regulation of gene expression; it is likely localized to the cytoplasm. There is no direct evidence supporting its role as a currently targeted therapeutic molecule, nor is it associated with specific disease or clinical biomarkers. Many of its aliases reflect status as a predicted gene or pseudogene, and its function is inferred by homology to better-studied TRIM family proteins[3]. Key clarifications: - TRIM49D2 is likely a pseudogene or predicted protein-coding gene with little published evidence of functional protein product or disease involvement; most databases classify it by homology, not experimental data[3]. - It is not considered an established therapeutic target (e.g., a receptor, enzyme targeted by drugs, transporter), nor are there drugs known to interact with TRIM49D2[3]. - Most functional annotations (ubiquitin ligase activity, immune regulation) are predictions drawn from domain structure and paralogy, not direct experimental validation for TRIM49D2 itself[3][2]. - The “incorrect” flag is true because there is no evidence this is an established drug target, and there is a high likelihood this is a non-functional or poorly characterized gene. The provided names also include multiple redundant and pseudogene-related synonyms, confirming limited functional evidence[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tripartite motif-containing protein 49D2 (TRIM49D2).